日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study

SH2B3突变在疑似髓系恶性肿瘤和急性白血病诊断中的意义:一项基于大规模NGS筛查研究的启示

Ben Dhia, Leïla; Wemeau, Mathieu; Fenwarth, Laurène; Marceau-Renaut, Alice; Fournier, Elise; Ducourneau, Benoît; Tricot, Sabine; Deschildt, Manon; Huchette, Pascal; Darre, Stéphane; Benhalima, Ilyes; Margat, Emilie; Bories, Claire; Dufossé, Maxime; Boyer, Thomas; Paubelle, Etienne; Charbonnier, Amandine; Lebon, Delphine; Hieulle, Julia; Dennetiere, Sophie; Malbranque, Zoé; Daniel, Adrien; Bruges, Judith; Pascal, Laurent; Brijs, Jan; Carpentier, Benjamin; Willaume, Alexandre; Coiteux, Valérie; Goursaud, Laure; Preudhomme, Claude; Nibourel, Olivier; Duployez, Nicolas

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

骨髓增生异常综合征分子国际预后评分系统的真实世界验证

Sauta, Elisabetta; Robin, Marie; Bersanelli, Matteo; Travaglino, Erica; Meggendorfer, Manja; Zhao, Lin-Pierre; Caballero Berrocal, Juan Carlos; Sala, Claudia; Maggioni, Giulia; Bernardi, Massimo; Di Grazia, Carmen; Vago, Luca; Rivoli, Giulia; Borin, Lorenza; D'Amico, Saverio; Tentori, Cristina Astrid; Ubezio, Marta; Campagna, Alessia; Russo, Antonio; Mannina, Daniele; Lanino, Luca; Chiusolo, Patrizia; Giaccone, Luisa; Voso, Maria Teresa; Riva, Marta; Oliva, Esther Natalie; Zampini, Matteo; Riva, Elena; Nibourel, Olivier; Bicchieri, Marilena; Bolli, Niccolo'; Rambaldi, Alessandro; Passamonti, Francesco; Savevski, Victor; Santoro, Armando; Germing, Ulrich; Kordasti, Shahram; Santini, Valeria; Diez-Campelo, Maria; Sanz, Guillermo; Sole, Francesc; Kern, Wolfgang; Platzbecker, Uwe; Ades, Lionel; Fenaux, Pierre; Haferlach, Torsten; Castellani, Gastone; Della Porta, Matteo Giovanni

Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use

利用数字聚合酶链式反应监测非A/B/D-NPM1突变急性髓系白血病中的微小残留病灶:可行性及临床应用

Lesieur, Auriane; Thomas, Xavier; Nibourel, Olivier; Boissel, Nicolas; Fenwarth, Laurène; De Botton, Stéphane; Fournier, Elise; Celli-Lebras, Karine; Raffoux, Emmanuel; Recher, Christian; Lambert, Juliette; Berthon, Céline; Pigneux, Arnaud; Itzykson, Raphael; Turlure, Pascal; Pautas, Cécile; Vargaftig, Jacques; Preudhomme, Claude; Dombret, Hervé; Duployez, Nicolas

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

原发性和继发性骨髓纤维化的基因组分析重新定义了ASXL1突变的预后影响:一项FIM研究

Luque Paz, Damien; Riou, Jérémie; Verger, Emmanuelle; Cassinat, Bruno; Chauveau, Aurélie; Ianotto, Jean-Christophe; Dupriez, Brigitte; Boyer, Françoise; Renard, Maxime; Mansier, Olivier; Murati, Anne; Rey, Jérôme; Etienne, Gabriel; Mansat-De Mas, Véronique; Tavitian, Suzanne; Nibourel, Olivier; Girault, Stéphane; Le Bris, Yannick; Girodon, François; Ranta, Dana; Chomel, Jean-Claude; Cony-Makhoul, Pascale; Sujobert, Pierre; Robles, Margot; Ben Abdelali, Raouf; Kosmider, Olivier; Cottin, Laurane; Roy, Lydia; Sloma, Ivan; Vacheret, Fabienne; Wemeau, Mathieu; Mossuz, Pascal; Slama, Borhane; Cussac, Vincent; Denis, Guillaume; Walter-Petrich, Anouk; Burroni, Barbara; Jézéquel, Nathalie; Giraudier, Stéphane; Lippert, Eric; Socié, Gérard; Kiladjian, Jean-Jacques; Ugo, Valérie

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

一项针对阿扎胞苷治疗失败后高危骨髓增生异常综合征和低原始细胞计数急性髓系白血病患者的 guadecitabine II 期研究。

Sébert, Marie; Renneville, Aline; Bally, Cécile; Peterlin, Pierre; Beyne-Rauzy, Odile; Legros, Laurence; Gourin, Marie-Pierre; Sanhes, Laurence; Wattel, Eric; Gyan, Emmanuel; Park, Sophie; Stamatoullas, Aspasia; Banos, Anne; Laribi, Kamel; Jueliger, Simone; Bevan, Luke; Chermat, Fatiha; Sapena, Rosa; Nibourel, Olivier; Chaffaut, Cendrine; Chevret, Sylvie; Preudhomme, Claude; Adès, Lionel; Fenaux, Pierre

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group

急性髓系白血病随访期间IDH1/2突变等位基因负荷的临床意义:法国ALFA研究组的研究

Ferret, Yann; Boissel, Nicolas; Helevaut, Nathalie; Madic, Jordan; Nibourel, Olivier; Marceau-Renaut, Alice; Bucci, Maxime; Geffroy, Sandrine; Celli-Lebras, Karine; Castaigne, Sylvie; Thomas, Xavier; Terré, Christine; Dombret, Hervé; Preudhomme, Claude; Renneville, Aline

Absence of CALR mutations in JAK2-negative polycythemia

JAK2阴性红细胞增多症中不存在CALR突变

Chauveau, Aurélie; Nibourel, Olivier; Tondeur, Sylvie; Luque Paz, Damien; Mansier, Olivier; Paul, Franciane; Wemeau, Mathieu; Preudhomme, Claude; Lippert, Eric; Ugo, Valérie

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia

微粒表型与原发性血小板增多症的驱动基因突变和不同的血栓形成风险相关。

Charpentier, Agnès; Lebreton, Aurélien; Rauch, Antoine; Bauters, Anne; Trillot, Nathalie; Nibourel, Oliver; Tintillier, Véronique; Wemeau, Mathieu; Demory, Jean-Loup; Preudhomme, Claude; Jude, Brigitte; Lecompte, Thomas; Cambier, Nathalie; Susen, Sophie

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia

BACH2 促进瓦尔登斯特伦巨球蛋白血症的惰性临床表现

Charles Herbaux, Elisabeth Bertrand, Guillemette Marot, Christophe Roumier, Nicolas Poret, Valérie Soenen, Olivier Nibourel, Catherine Roche-Lestienne, Natacha Broucqsault, Sylvie Galiègue-Zouitina, Eileen M Boyle, Guillemette Fouquet, Aline Renneville, Sabine Tricot, Franck Morschhauser, Claude Pre

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)

急性髓系白血病 (AML) 中与癌基因和耐药性相关的选择性外显子使用

Mohamed, Aminetou Mint; Balsat, Marie; Thenoz, Morgan; Koering, Catherine; Payen-Gay, Lea; Cheok, Meyling; Mortada, Hussein; Auboeuf, Didier; Pinatel, Christiane; El-Hamri, Mohamed; Dumontet, Charles; Cros, Emeline; Flandrin-Gresta, Pascale; Nibourel, Olivier; Preudhomme, Claude; Michallet, Mauricette; Thomas, Xavier; Nicolini, Franck; Solly, Françoise; Guyotat, Denis; Campos, Lydia; Wattel, Eric; Mortreux, Franck